Maeda, A <br/><br/>
Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Feb 2011 
 - 229-33 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2010.268  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Clopidogrel<br/>Coronary Artery Disease--drug therapy<br/>Cytochrome P-450 CYP2C19<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Polymorphism, Genetic<br/>Ticlopidine--analogs & derivatives